← Eichor
Study identifier: NCT05230446 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions

Condition: Multi Vessel Coronary Artery Disease · Non-ST Elevation Myocardial Infarction · Unstable Angina  ·  Sponsor: Erasmus Medical Center

PhaseNA
Planned participants609
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

This prospective, multicenter, non-randomized, single arm, objective performance goal (OPG) study is designed to evaluate clinical outcomes after complete revascularization by PCI and imaging guidance (OCT) in patients with multivessel coronary artery disease including left anterior descending (LAD) presenting with stable angina, or documented silent ischemia, or non-ST segment elevation acute coronary syndrome (NSTE-ACS).

This description comes directly from the study's public registry record.

Talk to the study team

Roberto Diletti, MD PhD  ·  +31 (0)10 70 352 60  ·  r.diletti@erasmusmc.nl

Hala Kakar, MD  ·  h.kakar.1@erasmusmc.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Erasmus Medical CenterRotterdam, South Holland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05230446